Stapled peptides offer a new approach to fighting brain-targeting viral infections
Peptide stapling—a chemical modification that stabilizes peptide structure—enhances the antiviral potential of peptides against neurotropic viruses like HSV and influenza by improving stability, bioavailability, and target binding.
Quick Facts
What This Study Found
Peptide stapling via hydrocarbon staples, lactam bridges, and metal-coordination bonds enhances peptide stability, bioavailability, cellular penetration, and target binding affinity for antiviral applications against neurotropic viruses including HSV and influenza.
Key Numbers
Reviews stapling techniques for peptides targeting HSV, VZV, HIV, poliovirus, enteroviruses, parechovirus, West Nile virus, and Japanese encephalitis virus.
How They Did This
Narrative review of stapling techniques and their application to antiviral peptide development, focusing on neurotropic viral targets.
Why This Research Matters
Neurotropic viral infections cause devastating diseases with limited treatment options. Stapled peptides could overcome the pharmacological limitations of natural antiviral peptides, creating a new class of drugs for brain-targeting viruses that resist current therapies.
The Bigger Picture
Peptide stapling represents a broader advance in peptide drug design that could transform multiple therapeutic areas. By solving the fundamental stability and bioavailability problems of peptide drugs, stapling technology may unlock the therapeutic potential of peptides that were previously too fragile for clinical use.
What This Study Doesn't Tell Us
Review of early-stage research; most stapled antiviral peptides are in preclinical development. No clinical trial data available. Manufacturing complexity and cost of stapled peptides may limit scalability.
Questions This Raises
- ?Which stapling technique offers the best balance of efficacy, stability, and manufacturability for antiviral applications?
- ?Can stapled peptides cross the blood-brain barrier effectively to treat neurotropic infections?
- ?How do stapled antiviral peptides compare to small molecule antivirals in terms of resistance development?
Trust & Context
- Key Stat:
- Stapling solves peptide drug limitations Chemical stapling of alpha-helices improves stability, bioavailability, and cellular penetration of antiviral peptides against neurotropic viruses
- Evidence Grade:
- Narrative review of preclinical research. Provides comprehensive overview of the technology but no clinical evidence for antiviral stapled peptides specifically.
- Study Age:
- Published in 2025; covers latest advances in stapled peptide antiviral development.
- Original Title:
- Unleashing the Antiviral Potential of Stapled Peptides: A New Frontier in Combating Human Neurotropic Viral Infections.
- Published In:
- Microbial biotechnology, 18(9), e70221 (2025)
- Authors:
- Patil, Sanskruti, Rahangdale, Rakesh, Pasupuleti, Mukesh(2), Santhoshkumar, Puttur, Hariharapura, Raghu Chandrashekar
- Database ID:
- RPEP-12985
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
What is peptide stapling?
Peptide stapling is a chemical modification that locks a peptide into its active three-dimensional shape (usually an alpha-helix) by adding a covalent bridge between amino acid side chains. This makes the peptide more resistant to degradation, better able to enter cells, and more effective at binding its target.
Why are brain viruses hard to treat?
Neurotropic viruses hide in the nervous system where they are protected by the blood-brain barrier, limiting drug access. They also resist many conventional antivirals. Stapled peptides could overcome these challenges by being more stable in the body and potentially crossing the blood-brain barrier more effectively.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12985APA
Patil, Sanskruti; Rahangdale, Rakesh; Pasupuleti, Mukesh; Santhoshkumar, Puttur; Hariharapura, Raghu Chandrashekar. (2025). Unleashing the Antiviral Potential of Stapled Peptides: A New Frontier in Combating Human Neurotropic Viral Infections.. Microbial biotechnology, 18(9), e70221. https://doi.org/10.1111/1751-7915.70221
MLA
Patil, Sanskruti, et al. "Unleashing the Antiviral Potential of Stapled Peptides: A New Frontier in Combating Human Neurotropic Viral Infections.." Microbial biotechnology, 2025. https://doi.org/10.1111/1751-7915.70221
RethinkPeptides
RethinkPeptides Research Database. "Unleashing the Antiviral Potential of Stapled Peptides: A Ne..." RPEP-12985. Retrieved from https://rethinkpeptides.com/research/patil-2025-unleashing-the-antiviral-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.